معرفی
Professor Robert Taylor is a leading academic in mitochondrial disease research at Newcastle University. His work focuses on genetic and molecular mechanisms underlying mitochondrial disorders, with contributions to understanding complex I and IV deficiencies, neurodevelopmental syndromes, and clinical-genetic correlations. He collaborates widely, publishing on topics like proteomics-based diagnostics, cerebellar degeneration mechanisms, and novel genetic variants. His research integrates clinical, biochemical, and genomic data to advance diagnostic guidelines and treatment strategies.
- Education/Training: Not explicitly stated in provided text.
- Affiliations: Newcastle University, multiple international collaborations.
Research Interests: Professor Taylor’s work spans mitochondrial genetics, metabolic disorders, and translational research. Key areas include mitochondrial tRNA mutations, complex assembly defects, and applications of proteomics in variant prioritization. He investigates clinical manifestations of genetic variants, such as in RYR1, PTPMT1, and NDUFA13, and their impacts on neurological and metabolic systems.
Articles Trends: Recent work emphasizes proteomic approaches for rapid variant identification, cerebellar degeneration mechanisms, and multi-omics analysis of mitochondrial dysfunction. Studies highlight clinical heterogeneity in cohorts like pediatric Egyptian patients and African populations with King-Denborough syndrome.
Advising/Grants: Leads multidisciplinary teams and participates in large-scale studies like the UK National Registry of Rare Kidney Diseases. Co-authors include prominent researchers in mitochondrial medicine, indicating collaborative grant activities.
Labs/Teams: Likely part of Newcastle’s Mitochondrial Research Group, contributing to diagnostic guideline development (e.g., UK Best Practice Guidelines).